In-Silico Molecular Binding Prediction for Human Drug Targets Using Deep Neural Multi-Task Learning
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
In in-silico prediction for molecular binding of human genomes, promising results have been demonstrated by deep neural multi-task learning due to its strength in training tasks with imbalanced data and its ability to avoid over-fitting. Although the interrelation between tasks is known to be important for successful multi-task learning, its adverse effect has been underestimated. In this study, we used molecular interaction data of human targets from ChEMBL to train and test various multi-task and single-task networks and examined the effectiveness of multi-task learning for different compositions of targets. Targets were clustered based on sequence similarity in their binding domains and various target sets from clusters were chosen. By comparing the performance of deep neural architectures for each target set, we found that similarity within a target set is highly important for reliable multi-task learning. For a diverse target set or overall human targets, the performance of multi-task learning was lower than single-task learning, but outperformed single-task for the target set containing similar targets. From this insight, we developed Multiple Partial Multi-Task learning, which is suitable for binding prediction for human drug targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436 · cited 1×
“Compound structures were extracted in Simplified Molecular Input Line Entry System (SMILES) format [29].”
MethodBiopython: freely available python tools for computational molecular biology and bioinformatics
Cock, P. J. A., Antao, T., Chang, J. T., Chapman, B. A., Cox, C. J., Dalke, A., Friedberg, I., Hamelryck, T., Kauff, F., Wilczynski, B., et al. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp163 · Cited by 6,080
Bengio, Y., Louradour, J., Collobert, R., & Weston, J. (2009) · Proceedings of the 26th Annual International Conference on Machine Learning · doi:10.1145/1553374.1553380 · Cited by 5,366
A unified architecture for natural language processing: deep neural networks with multitask learning
Collobert, R., & Weston, J. (2008) · Proceedings of the 25th international conference on Machine learning - ICML '08 · doi:10.1145/1390156.1390177 · Cited by 5,058
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Relating protein pharmacology by ligand chemistry
Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007) · Nature Biotechnology · doi:10.1038/nbt1284 · Cited by 2,402
What is the best multi-stage architecture for object recognition?
Jarrett, K., Kavukcuoglu, K., Ranzato, M. A., & LeCun, Y. (2009) · 2009 IEEE 12th International Conference on Computer Vision · doi:10.1109/iccv.2009.5459469 · Cited by 2,153 · cited 1×
“Deep learning uses multiple layers with non-linear activation functions for effective learning of complex relationships hidden within the data [10].”
BackgroundVirtual screening of chemical libraries
Shoichet, B. K. (2004) · Nature · doi:10.1038/nature03197 · Cited by 1,425
Wang, L., Wu, Y., Deng, Y., Kim, B., Pierce, L., Krilov, G., Lupyan, D., Robinson, S., Dahlgren, M. K., Greenwood, J., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/ja512751q · Cited by 1,313 · cited 1×
“Predicting molecular binding between the ligand and target enables a highly-efficient virtual screening for specific targets and early avoidance of drug toxicity [6,7].”
BackgroundDeep Neural Nets as a Method for Quantitative Structure–Activity Relationships
Ma, J., Sheridan, R. P., Liaw, A., Dahl, G. E., & Svetnik, V. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500747n · Cited by 1,159 · cited 1×
“Deep learning, which has been successful in many research fields, has outperformed other machine learning tasks in drug-target binding prediction [1,8,9].”
BackgroundDeepTox: toxicity prediction using deep learning
Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00080 · Cited by 1,081
Large-scale comparison of machine learning methods for drug target prediction on ChEMBL
Mayr, A., Klambauer, G., Unterthiner, T., Steijaert, M., Wegner, J. K., Ceulemans, H., Clevert, D.-A., & Hochreiter, S. (2018) · Chemical Science · doi:10.1039/c8sc00148k · Cited by 584
Can We Learn To Distinguish between “Drug-like” and “Nondrug-like” Molecules?
Ajay, Walters, W. P., & Murcko, M. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970666c · Cited by 484
MolGAN: An implicit generative model for small molecular graphs
De Cao, N., & Kipf, T. (2018) · arXiv · doi:10.48550/arxiv.1805.11973 · Cited by 442
Time-Split Cross-Validation as a Method for Estimating the Goodness of Prospective Prediction.
Sheridan, R. P. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400084k · Cited by 376 · cited 2×
“To avoid any unexpected bias from compound specificity [25] and hyperparameter selection, the validation process was performed using nested cluster cross-validation [22,26].”
BackgroundMethodIs Multitask Deep Learning Practical for Pharma?
Ramsundar, B., Liu, B., Wu, Z., Verras, A., Tudor, M., Sheridan, R. P., & Pande, V. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00146 · Cited by 263 · cited 7×
“This is because they can build independent mini-batches for each task [2,23].”
BackgroundMethodInfluentialDesign of efficient computational workflows for in silico drug repurposing
Vanhaelen, Q., Mamoshina, P., Aliper, A. M., Artemov, A., Lezhnina, K., Ozerov, I., Labat, I., & Zhavoronkov, A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.09.019 · Cited by 150 · cited 1×
“Computer aided drug design (CADD) assists in the retrieval of viable drugs from a large-scale compound database, thereby substantially reducing the time and cost for clinical approval [5].”
Background
Cited by
Artificial intelligence in drug discovery: recent advances and future perspectives
Jiménez-Luna, J., Grisoni, F., Weskamp, N., & Schneider, G. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1909567 · Cited by 464
The transformational role of GPU computing and deep learning in drug discovery
Pandey, M., Fernandez, M., Gentile, F., Isayev, O., Tropsha, A., Stern, A. C., & Cherkasov, A. (2022) · Nature Machine Intelligence · doi:10.1038/s42256-022-00463-x · Cited by 255
“…of the predictors of the pharmacokinetic behaviour of therapeutics and their adverse effects 42 , the prediction of small molecule–protein binding 43 , the determination of chemotherapeutic responses of carcinogenic cells 44 , the quantitative estimation of drug sensitivity 45 and quantitative…”
BackgroundIntegrating Machine Learning with Human Knowledge
Deng, C., Ji, X., Rainey, C., Zhang, J., & Lu, W. (2020) · iScience · doi:10.1016/j.isci.2020.101656 · Cited by 243
“Deep learning (LeCun et al., 2015) relaxes such requirements by stacking multiple layers of artificial neural modules, most of which are subject to learning.”
Background
Metadata
- Authors
- Lee, K., & Kim, D.
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2019-11-07
- Volume
- 10
- Issue
- 11
- Pages
- 906
- ISSN
- 2073-4425 (ISSN-L)
- OpenAlex
- W2987553406
- Cited by
- 74
- References
- 18
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.